Study finds gabapentinoid treatment does not elevate risk of self‐harm
A population‐based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self‐harm during treatment. Risk of self‐harm was elevated during pre‐ and post‐treatment periods, the investigators found. Study results were published online April 30, 2025 in The BMJ .
Publication Details
- Journal
- The Brown University Psychopharmacology Update
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1002/pu.31344
- Primary Topic
- Suicide and Self-Harm Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00